GRANT AWARDUpdated 4 days ago

Universite Ouaga I Professeur Joseph ki-ZERBO: 101137359 - Changemaker - Promoting co-designed sustainable health interventions with young changemakers for reduced risk of non-communicable diseases (NCDS) in urban Burkina Faso, Kenya and Tanzania

European Health and Digital Executive Agency (HADEA) awarded a grant of EUR 154,413.87 to UNIVERSITE OUAGA I PROFESSEUR JOSEPH KI-ZERBO for work in Burkina Faso, listed in the EU Financial Transparency System for 2023.

Into French, Portuguese or Arabic, machine translated, with the original kept beside it.
Key Information
Awarded by
European Health and Digital Executive Agency (HADEA)
Location
Burkina Faso
Status
Awarded
Category
Grant
Award Amount
EUR 154,414
Reference
EU-FTS-2023-JAG.1377348.1-85b8bc444b
Procurement Method
Grant
Language
English
Awarded to
UNIVERSITE OUAGA I PROFESSEUR JOSEPH KI-ZERBO
Contract Start
Jan 1, 2024
Contract End
Dec 31, 2027

Overview

EU grant type as the FTS states it: Action Grant. Budget: EU Budget - European Commission.

Programme: 1.0.11 - Horizon Europe

Source: EU Financial Transparency System (European Commission), published under Creative Commons Attribution 4.0 International (CC BY 4.0), under the Commission's reuse policy (Commission Decision 2011/833/EU) (https://creativecommons.org/licenses/by/4.0/). Read from https://ec.europa.eu/budget/financial-transparency-system/download/2023_FTS_dataset_en.csv. Reshaped by All Business Africa into this record; amounts and currency are as the funder states them.

Similar contract awards

View all
Confederation paysanne du Faso: Appui à l'engagement citoyen des jeunes agriculteurs et agricultrices des exploitations familialesBurkina FasoCroix rouge burkinabe association*: EU aid volunteers deployment: EU aid volunteers supporting and complementing humanitarian aid in middle east, Africa, asia and southern and Central americaBurkina FasoGroupe de recherche action en sante sarl*gras: 815643 - Vasa - Vaccine against schistosomiasis for Africa. A phase I clinical study of the schistoshield® anti-schistosomiasis vaccine in adults in endemic areas of sub-saharan AfricaBurkina FasoGroupe de recherche action en sante sarl*gras: 815643 - Vasa - Vaccine against schistosomiasis for Africa. A phase I clinical study of the schistoshield® anti-schistosomiasis vaccine in adults in endemic areas of sub-saharan AfricaBurkina FasoAssociation tin tua( att): Jeunesse et démocratie : De l'observation à l'actionBurkina FasoUniversite Ouaga I Professeur Joseph ki-ZERBO: 815643 - Vasa - Vaccine against schistosomiasis for Africa. A phase I clinical study of the schistoshield® anti-schistosomiasis vaccine in adults in endemic areas of sub-saharan AfricaBurkina Faso